358 related articles for article (PubMed ID: 19098320)
1. Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats.
Drel VR; Xu W; Zhang J; Kador PF; Ali TK; Shin J; Julius U; Slusher B; El-Remessy AB; Obrosova IG
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1778-90. PubMed ID: 19098320
[TBL] [Abstract][Full Text] [Related]
2. Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis.
Drel VR; Pacher P; Ali TK; Shin J; Julius U; El-Remessy AB; Obrosova IG
Int J Mol Med; 2008 Jun; 21(6):667-76. PubMed ID: 18506358
[TBL] [Abstract][Full Text] [Related]
3. Poly(ADP-ribose) polymerase inhibitors counteract diabetes- and hypoxia-induced retinal vascular endothelial growth factor overexpression.
Obrosova IG; Minchenko AG; Frank RN; Seigel GM; Zsengeller Z; Pacher P; Stevens MJ; Szabó C
Int J Mol Med; 2004 Jul; 14(1):55-64. PubMed ID: 15202016
[TBL] [Abstract][Full Text] [Related]
4. Poly(Adenosine 5'-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy.
Drel VR; Xu W; Zhang J; Pavlov IA; Shevalye H; Slusher B; Obrosova IG
Endocrinology; 2009 Dec; 150(12):5273-83. PubMed ID: 19854869
[TBL] [Abstract][Full Text] [Related]
5. Na+/H+-exchanger-1 inhibition counteracts diabetic cataract formation and retinal oxidative-nitrative stress and apoptosis.
Lupachyk S; Stavniichuk R; Komissarenko JI; Drel VR; Obrosov AA; El-Remessy AB; Pacher P; Obrosova IG
Int J Mol Med; 2012 Jun; 29(6):989-98. PubMed ID: 22407349
[TBL] [Abstract][Full Text] [Related]
6. Poly(ADP-Ribose) Polymerase Inhibition Improves Corneal Epithelial Innervation and Wound Healing in Diabetic Rats.
Byun YS; Kang B; Yoo YS; Joo CK
Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1948-55. PubMed ID: 25711635
[TBL] [Abstract][Full Text] [Related]
7. Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model.
Shevalye H; Stavniichuk R; Xu W; Zhang J; Lupachyk S; Maksimchyk Y; Drel VR; Floyd EZ; Slusher B; Obrosova IG
Biochem Pharmacol; 2010 Apr; 79(7):1007-14. PubMed ID: 19945439
[TBL] [Abstract][Full Text] [Related]
8. Diabetes-induced overexpression of endothelin-1 and endothelin receptors in the rat renal cortex is mediated via poly(ADP-ribose) polymerase activation.
Minchenko AG; Stevens MJ; White L; Abatan OI; Komjáti K; Pacher P; Szabó C; Obrosova IG
FASEB J; 2003 Aug; 17(11):1514-6. PubMed ID: 12824290
[TBL] [Abstract][Full Text] [Related]
9. Exogenous SOD mimetic tempol ameliorates the early retinal changes reestablishing the redox status in diabetic hypertensive rats.
Rosales MA; Silva KC; Lopes de Faria JB; Lopes de Faria JM
Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4327-36. PubMed ID: 20335612
[TBL] [Abstract][Full Text] [Related]
10. Poly(ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors Reduce Reactive Gliosis and Improve Angiostatin Levels in Retina of Diabetic Rats.
Guzyk MM; Tykhomyrov AA; Nedzvetsky VS; Prischepa IV; Grinenko TV; Yanitska LV; Kuchmerovska TM
Neurochem Res; 2016 Oct; 41(10):2526-2537. PubMed ID: 27255598
[TBL] [Abstract][Full Text] [Related]
11. Effect of the regimen of Gaoshan Hongjingtian on the mechanism of poly (ADP-ribose) polymerase regulation of nuclear factor kappa B in the experimental diabetic retinopathy.
Zhao HS; Shi XY; Wei WB; Wang NL
Chin Med J (Engl); 2013; 126(9):1693-9. PubMed ID: 23652053
[TBL] [Abstract][Full Text] [Related]
12. Poly(ADP-ribosyl)ation enhancement in brain cell nuclei is associated with diabetic neuropathy.
Kuchmerovska T; Shymanskyy I; Donchenko G; Kuchmerovskyy M; Pakirbaieva L; Klimenko A
J Diabetes Complications; 2004; 18(4):198-204. PubMed ID: 15207836
[TBL] [Abstract][Full Text] [Related]
13. Peroxynitrite decomposition catalyst, FP15, and poly(ADP-ribose) polymerase inhibitor, PJ34, inhibit leukocyte entrapment in the retinal microcirculation of diabetic rats.
Sugawara R; Hikichi T; Kitaya N; Mori F; Nagaoka T; Yoshida A; Szabo C
Curr Eye Res; 2004 Jul; 29(1):11-6. PubMed ID: 15370362
[TBL] [Abstract][Full Text] [Related]
14. Aldose reductase inhibition counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic rat kidney and high-glucose-exposed human mesangial cells.
Drel VR; Pacher P; Stevens MJ; Obrosova IG
Free Radic Biol Med; 2006 Apr; 40(8):1454-65. PubMed ID: 16631535
[TBL] [Abstract][Full Text] [Related]
15. Oxidative stress-induced, poly(ADP-ribose) polymerase-dependent upregulation of ET-1 expression in chronic diabetic complications.
Chiu J; Xu BY; Chen S; Feng B; Chakrabarti S
Can J Physiol Pharmacol; 2008 Jun; 86(6):365-72. PubMed ID: 18516100
[TBL] [Abstract][Full Text] [Related]
16. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.
Obrosova IG; Pacher P; Szabó C; Zsengeller Z; Hirooka H; Stevens MJ; Yorek MA
Diabetes; 2005 Jan; 54(1):234-42. PubMed ID: 15616034
[TBL] [Abstract][Full Text] [Related]
17. Notch signaling protects retina from nuclear factor-κB- and poly-ADP-ribose-polymerase-mediated apoptosis under high-glucose stimulation.
Qin X; Zhang Z; Xu H; Wu Y
Acta Biochim Biophys Sin (Shanghai); 2011 Sep; 43(9):703-11. PubMed ID: 21813561
[TBL] [Abstract][Full Text] [Related]
18. Poly(ADP-ribose) polymerase inhibition reverses nitrergic neurovascular dysfunctions in penile erectile tissue from streptozotocin-diabetic mice.
Nangle MR; Cotter MA; Cameron NE
J Sex Med; 2010 Oct; 7(10):3396-403. PubMed ID: 20456626
[TBL] [Abstract][Full Text] [Related]
19. Oxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisited.
Obrosova IG; Drel VR; Pacher P; Ilnytska O; Wang ZQ; Stevens MJ; Yorek MA
Diabetes; 2005 Dec; 54(12):3435-41. PubMed ID: 16306359
[TBL] [Abstract][Full Text] [Related]
20. Caspase-14: a novel caspase in the retina with a potential role in diabetic retinopathy.
Al-Shabrawey M; Ahmad S; Megyerdi S; Othman A; Baban B; Palenski TL; Shin ES; Gurel Z; Hsu S; Sheibani N
Mol Vis; 2012; 18():1895-906. PubMed ID: 22876114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]